Jefferies Group’s Medifast MED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-3,069
Closed -$318K 2809
2019
Q3
$318K Sell
3,069
-3,045
-50% -$327K ﹤0.01% 2148
2019
Q2
$784K Sell
6,114
-4,062
-40% -$564K 0.01% 1423
2019
Q1
$1.3M Buy
+10,176
New +$1.29M 0.01% 1135
2018
Q3
Sell
-2,789
Closed -$447K 2618
2018
Q2
$447K Buy
+2,789
New +$357K ﹤0.01% 1653
2017
Q3
Sell
-9,178
Closed -$381K 2510
2017
Q2
$381K Sell
9,178
-832
-8% -$36.2K ﹤0.01% 1739
2017
Q1
$444K Buy
10,010
+998
+11% +$43K ﹤0.01% 1654
2016
Q4
$375K Buy
+9,012
New +$363K ﹤0.01% 1689
2015
Q3
Sell
-262
Closed -$8K 2734
2015
Q2
$8K Buy
+262
New +$8.31K ﹤0.01% 2876

Other funds holding MED

Jefferies Group's MED Position: Q4 2019 in Review

Jefferies Group sold out of Medifast (MED) in Q4 2019, closing a stake of 3,069 shares — an estimated $318K sold.

Jefferies Group first reported a position in MED in Q2 2015 and held it in 8 quarters. The position peaked at $1.3M in Q1 2019. 219 funds tracked by Wall St. Rank hold MED as of Q4 2019.

  • Jefferies Group reported no remaining Medifast position as of Q4 2019 after selling out during the quarter.
  • Jefferies Group sold 3,069 Medifast shares in Q4 2019, an estimated $318K.
  • Jefferies Group first reported a position in Medifast in Q2 2015 and held it in 8 quarters.
  • Jefferies Group's Medifast position peaked at $1.3M in Q1 2019.
  • 219 funds tracked by Wall St. Rank held Medifast as of Q4 2019.

Based on Jefferies Group's 13F filing for Q4 2019, filed 13 Feb 2020.